analysis of plasminogen genetic variants in multiple sclerosis patients
Clicks: 284
ID: 172019
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
284 views
22 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #41 of 194 articles by views in separation and purification technology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Multiple sclerosis (MS) is a prevalent neurological disease of complex etiology. Here, we describe the characterization of a multi-incident MS family that nominated a rare missense variant (p.G420D) in plasminogen (PLG) as a putative genetic risk factor for MS. Genotyping of PLG p.G420D (rs139071351) in 2160 MS patients, and 886 controls from Canada, identified 10 additional probands, two sporadic patients and one control with the variant. Segregation in families harboring the rs139071351 variant, identified p.G420D in 26 out of 30 family members diagnosed with MS, 14 unaffected parents, and 12 out of 30 family members not diagnosed with disease. Despite considerably reduced penetrance, linkage analysis supports cosegregation of PLG p.G420D and disease. Genotyping of PLG p.G420D in 14446 patients, and 8797 controls from Canada, France, Spain, Germany, Belgium, and Austria failed to identify significant association with disease (P = 0.117), despite an overall higher prevalence in patients (OR = 1.32; 95% CI = 0.93–1.87). To assess whether additional rare variants have an effect on MS risk, we sequenced PLG in 293 probands, and genotyped all rare variants in cases and controls. This analysis identified nine rare missense variants, and although three of them were exclusively observed in MS patients, segregation does not support pathogenicity. PLG is a plausible biological candidate for MS owing to its involvement in immune system response, blood-brain barrier permeability, and myelin degradation. Moreover, components of its activation cascade have been shown to present increased activity or expression in MS patients compared to controls; further studies are needed to clarify whether PLG is involved in MS susceptibility.
| Reference Key |
sadovnick2016g3:analysis
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;A. Dessa Sadovnick;Anthony L. Traboulsee;Cecily Q. Bernales;Jay P. Ross;Amanda L. Forwell;Irene M. Yee;Lena Guillot-Noel;Bertrand Fontaine;Isabelle Cournu-Rebeix;Antonio Alcina;Maria Fedetz;Guillermo Izquierdo;Fuencisla Matesanz;Kelly Hilven;Bénédicte Dubois;An Goris;Ianire Astobiza;Iraide Alloza;Alfredo Antigüedad;Koen Vandenbroeck;Denis A. Akkad;Orhan Aktas;Paul Blaschke;Mathias Buttmann;Andrew Chan;Joerg T. Epplen;Lisa-Ann Gerdes;Antje Kroner;Christian Kubisch;Tania Kümpfel;Peter Lohse;Peter Rieckmann;Uwe K. Zettl;Frauke Zipp;Lars Bertram;Christina M Lill;Oscar Fernandez;Patricia Urbaneja;Laura Leyva;Jose Carlos Alvarez-Cermeño;Rafael Arroyo;Aroa M. Garagorri;Angel García-Martínez;Luisa M. Villar;Elena Urcelay;Sunny Malhotra;Xavier Montalban;Manuel Comabella;Thomas Berger;Franz Fazekas;Markus Reindl;Mascha C. Schmied;Alexander Zimprich;Carles Vilariño-Güell |
| Journal | separation and purification technology |
| Year | 2016 |
| DOI |
10.1534/g3.116.030841
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.